Literature DB >> 16740543

NICE recommends aromatase inhibitors for early breast cancer.

Susan Mayor.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16740543      PMCID： PMC1473088          DOI： 10.1136/bmj.332.7553.1292-d

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  2 in total

1.  Risk of dementia among postmenopausal breast cancer survivors treated with aromatase inhibitors versus tamoxifen: a cohort study using primary care data from the UK.

Authors:  Susan E Bromley; Anthony Matthews; Liam Smeeth; Susannah Stanway; Krishnan Bhaskaran
Journal:  J Cancer Surviv       Date:  2019-07-18       Impact factor: 4.442

2.  An updated review on the efficacy of adjuvant endocrine therapies in hormone receptor-positive early breast cancer.

Authors:  S Verma; S Sehdev; A Joy; Y Madarnas; J Younus; J A Roy
Journal:  Curr Oncol       Date:  2009-07       Impact factor: 3.677
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.